Blood management in total joint arthroplasty

Area of Science:

• Orthopedic Surgery
• Anesthesiology
• Transfusion Medicine

Background:

• Total joint arthroplasty (TJA) is frequently associated with significant perioperative blood loss.
• Uncontrolled hemorrhage can lead to serious complications and increased patient morbidity.
• Effective blood management strategies are essential for optimizing patient outcomes in TJA.

Purpose of the Study:

• To review current techniques for managing perioperative blood loss in TJA.
• To discuss the clinical consequences of perioperative anemia.
• To outline potential problems associated with allogeneic blood transfusions.

Main Methods:

• Literature review of established and emerging blood management strategies.
• Analysis of the physiological effects and clinical impact of perioperative anemia.
• Examination of transfusion-related adverse events.

Main Results:

• Multiple blood management strategies exist, including autologous donation, pharmacologic agents, hemodilution, and cell salvage.
• Perioperative anemia can negatively impact recovery and increase the risk of complications.
• Allogeneic blood transfusions carry inherent risks that must be considered.

Conclusions:

• A multimodal approach to blood management is recommended for TJA patients.
• Minimizing blood loss and managing anemia are critical for patient safety and recovery.
• Careful consideration of transfusion risks versus benefits is necessary.